Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Strides Pharma gets USFDA approval for Oral Dosage facility in Singapore

      Strides Pharma gets USFDA approval for Oral Dosage facility in Singapore

      Medical Dialogues Bureau28 March 2019 9:30 AM IST
      With the commercialisation of this facility, the Strides Pharma will join the league of global pharmaceutical companies having manufacturing and...
      Purdue Pharma agrees to pay $270 million to settle opioid case

      Purdue Pharma agrees to pay $270 million to settle opioid case

      Medical Dialogues Bureau28 March 2019 9:15 AM IST
      Purdue Pharma introduced OxyContin in the 1990s and marketed it hard to doctors, making tens of billions of dollars from the drug. But the company has...
      AstraZeneca gets EU nod to diabetes drug Forxiga

      AstraZeneca gets EU nod to diabetes drug Forxiga

      Medical Dialogues Bureau27 March 2019 2:55 PM IST
      Farxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
      February has been a month of achievements, robust initiatives and success at AMRI Hospitals

      February has been a month of achievements, robust initiatives and success at AMRI Hospitals

      Medical Dialogues Bureau26 March 2019 9:05 AM IST
      New Delhi: With an utmost commitment towards delivering the best medical services, AMRI Hospitals, Bhubaneshwar, has always been at the forefront of...
      Home Remedies That Offer Relief From Food Poisoning

      Home Remedies That Offer Relief From Food Poisoning

      Medical Dialogues Bureau26 March 2019 9:00 AM IST
      New Delhi: We love street food delicacies like gol guppas and chole bhature, and whenever we get a chance, we grab a bite. However, we don't always...
      USFDA Caution: Lupin gets OAI letter for MP plant

      USFDA Caution: Lupin gets OAI letter for MP plant

      Medical Dialogues Bureau17 March 2019 9:45 AM IST
      Lupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Mandideep (Unit 1) facility...
      USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

      USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

      Medical Dialogues Bureau23 Feb 2019 9:30 AM IST
      "The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
      Johnson & Johnson receives federal summon related to baby powder litigation

      Johnson & Johnson receives federal summon related to baby powder litigation

      Medical Dialogues Bureau22 Feb 2019 9:25 AM IST
      The company said it intends to "cooperate fully with these inquiries and will continue to defend the Company in the talc-related litigation."U.S:...
      Abbott introduces diagnostic test Determine HBsAg 2 to accelerate hepatitis B care

      Abbott introduces diagnostic test Determine HBsAg 2 to accelerate hepatitis B care

      Medical Dialogues Bureau22 Feb 2019 9:15 AM IST
      U.S: Healthcare firm, Abbott has secured CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface...
      Canada to unveil budget, outline better drug coverage

      Canada to unveil budget, outline better drug coverage

      Medical Dialogues Bureau21 Feb 2019 9:15 AM IST
      Although Canada has a publicly funded health care system, prescription drug is largely covered by private insurance and public plans that are geared...
      Nestle India to launch nearly three dozen products in 2019, eyes higher exports

      Nestle India to launch nearly three dozen products in 2019, eyes higher exports

      Medical Dialogues Bureau20 Feb 2019 9:30 AM IST
      Nestle, whose 6 per cent revenues come from exports, is now looking to tap more overseas markets by targeting countries with higher Indian diaspora...
      Australia approves new drug CONTRAVE to fight obesity

      Australia approves new drug CONTRAVE to fight obesity

      Medical Dialogues Bureau18 Feb 2019 9:15 AM IST
      Contrave is not listed on Pharmaceutical Benefits Scheme - meaning the federal government is not subsidising it - and will cost those who use it about...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok